These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19688314)

  • 21. [Hypertension combined with atherosclerotic lesions in carotid arteries: should angiotensin converting enzyme inhibitors be prescribed?].
    Fomin VV; Moiseev SV
    Kardiologiia; 2005; 45(12):99-102. PubMed ID: 16353055
    [No Abstract]   [Full Text] [Related]  

  • 22. Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group.
    Jukema JW; Zwinderman AH; van Boven AJ; Reiber JH; Van der Laarse A; Lie KI; Bruschke AV
    Arterioscler Thromb Vasc Biol; 1996 Mar; 16(3):425-30. PubMed ID: 8630669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 26-week toxicological study of Xuezhikang (XZK), red yeast rice extract, in Beagle dogs with a 4-week recovery period.
    Li C; Su C; Wang Y; Gao Y; Wang H; Tian J; Fu F
    Regul Toxicol Pharmacol; 2020 Nov; 117():104781. PubMed ID: 32896614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study.
    Ahmed FW; Rider R; Glanville M; Narayanan K; Razvi S; Weaver JU
    Cardiovasc Diabetol; 2016 Aug; 15(1):116. PubMed ID: 27561827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Xuezhikang improves the outcomes of cardiopulmonary resuscitation in rats by suppressing the inflammation response through TLR4/NF-κB pathway.
    Liang L; Shao W; Shu T; Zhang Y; Xu S; Guo L; Zhou Y; Huang H; Sun P
    Biomed Pharmacother; 2019 Jun; 114():108817. PubMed ID: 30953818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mobilization of putative high-proliferative-potential endothelial colony-forming cells during antihypertensive treatment in patients with essential hypertension.
    Benndorf RA; Gehling UM; Appel D; Maas R; Schwedhelm E; Schlagner K; Silberhorn E; Hossfeld DK; Rogiers X; Böger R
    Stem Cells Dev; 2007 Apr; 16(2):329-38. PubMed ID: 17521243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating endothelial progenitor cells in periodontitis.
    Jönsson D; Spinell T; Vrettos A; Stoecklin-Wasmer C; Celenti R; Demmer RT; Kebschull M; Papapanou PN
    J Periodontol; 2014 Dec; 85(12):1739-47. PubMed ID: 25101916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lacidipine improves endothelial repair capacity of endothelial progenitor cells from patients with essential hypertension.
    Liu X; Zhang GX; Zhang XY; Xia WH; Yang Z; Su C; Qiu YX; Xu SY; Zhan H; Tao J
    Int J Cardiol; 2013 Oct; 168(4):3317-26. PubMed ID: 23642821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of pravastatin in dyslipidaemic patients with and without hypertension.
    Tsukiyama H; Otsuka K
    J Hypertens Suppl; 1993 Dec; 11(5):S346-7. PubMed ID: 8158416
    [No Abstract]   [Full Text] [Related]  

  • 30. Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin.
    David S; Kümpers P; Lukasz A; Kielstein JT; Haller H; Fliser D
    J Hypertens; 2009 Aug; 27(8):1641-7. PubMed ID: 19390459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium.
    Luo D; Kim JH; Park C; Oh E; Park JB; Cui JH; Cao QR; Lee BJ
    Int J Pharm; 2017 May; 523(1):343-356. PubMed ID: 28330645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pravastatin has an additional depressor effect in patients undergoing long-term treatment with antihypertensive drugs.
    Ikeda T; Sakurai J; Nakayama D; Takahashi Y; Matsuo K; Shibuya Y; Gomi T; Moriya H; Kobayashi S
    Am J Hypertens; 2004 Jun; 17(6):502-6. PubMed ID: 15177522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral perfusion and tissue oxygenation improvement induced by antihypertensive medication combined with lipoidoproteinosis treatment.
    Cicco G; Vicenti P; Pirrelli A; van der Kleij AJ
    Adv Exp Med Biol; 1997; 411():261-6. PubMed ID: 9269435
    [No Abstract]   [Full Text] [Related]  

  • 34. Antihypertensive and renal effects of isradipine in essential hypertension: focus on renin system activity.
    Allikmets K; Parik T; Teesalu R
    Angiology; 1997 Nov; 48(11):977-83. PubMed ID: 9373050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of Xuezhikang on blood pressure in hypertensive patients with previous myocardial infarction: data from the Chinese Coronary Secondary Prevention Study (CCSPS).
    Li JJ; Lu ZL; Kou WR; Chen Z; Wu YF; Yu XH; Zhao YC;
    Clin Exp Hypertens; 2010; 32(8):491-8. PubMed ID: 21091365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xuezhikang therapy increases miR-33 expression in patients with low HDL-C levels.
    Cao R; Bai Y; Sun L; Zheng J; Zu M; Du G; Ye P
    Dis Markers; 2014; 2014():781780. PubMed ID: 24591767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Xuezhikang () reduced renal cell apoptosis in streptozocin-induced diabetic rats through regulation of Bcl-2 family.
    Lu WN; Zheng FP; Lai DW; Li H
    Chin J Integr Med; 2016 Aug; 22(8):611-8. PubMed ID: 25847779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined treatment with captopril, hydrochlorothiazide and pravastatin in dyslipidemic hypertensive patients.
    Waeber B; Greminger P; Riesen W; Darioli R; Simeon-Dubach D; Wunderlin R
    Blood Press; 1995 Nov; 4(6):358-62. PubMed ID: 8746603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial function in subjects with isolated low HDL cholesterol: role of nitric oxide and circulating progenitor cells.
    Higashi Y; Matsuoka H; Umei H; Sugano R; Fujii Y; Soga J; Kihara Y; Chayama K; Imaizumi T
    Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E202-9. PubMed ID: 19903864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Erythrocyte aggregation in patients with arterial hypertension and dyslipidemia treated with pravastatin].
    Medvedev IN; Skoriatina IA
    Klin Med (Mosk); 2014; 92(11):34-8. PubMed ID: 25796944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.